PT Millennium Pharmacon International Tbk SDPC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 6.69
- Price/Sales
- 0.05
- Dividend Yield (Trailing)
- 1.81%
- Dividend Yield (Forward)
- 1.81%
- Total Yield
- 1.81%
Company Profile
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The operating segments of the group are Prescription medicine, Non-prescription medicine, and Medical devices, of which the majority of the revenue is derived from the Prescription Medicine segment.. The company's geographical segments are Java, Sumatera, Kalimantan, Sulawesi, and Bali.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,170
- Website
- http://www.mpi-indonesia.co.id
Valuation
|
Metric
|
SDPC
|
|---|---|
Price/Earnings (Normalized) | 6.69 |
Price/Book Value | 0.61 |
Price/Sales | 0.05 |
Price/Cash Flow | — |
Price/Earnings
SDPC
Financial Strength
|
Metric
|
SDPC
|
|---|---|
Quick Ratio | 0.61 |
Current Ratio | 1.12 |
Interest Coverage | 1.63 |
Quick Ratio
SDPC
Profitability
|
Metric
|
SDPC
|
|---|---|
Return on Assets (Normalized) | 1.56% |
Return on Equity (Normalized) | 9.24% |
Return on Invested Capital (Normalized) | 6.52% |
Return on Assets
SDPC
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| Cgvqhsdk | Jzrkgqx | $62.1 Bil | |||
| Cencora Inc
COR
| Nxhgfrmll | Bdwnqs | $43.9 Bil | |||
| Cardinal Health Inc
CAH
| Bjsrrblg | Xyyrwv | $26.4 Bil | |||
| Shanghai Pharmaceuticals Holding Co Ltd Class H
SHPMF
| — | Yblttm | $9.2 Bil | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H
SHPMY
| — | Nggdbw | $9.2 Bil | |||
| Sinopharm Group Co Ltd
SHTDF
| — | Mbxdr | $7.5 Bil | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | Qxtjj | $7.5 Bil | |||
| Amplifon SpA Az nom Post Frazionamento
AMFPF
| — | Rdbbv | $6.6 Bil | |||
| Ebos Group Ltd ADR
EBOSY
| — | Pqyzfh | $4.5 Bil | |||
| Medipal Holdings Corp ADR
MAHLY
| — | Wwqd | $3.7 Bil |
United States